Products

Built on science. Driven by quality.

Marketed Products

0

ATC
L04AX04

Name of Medicinal Product

Lenalidomide/Abbio

Active Substance

Lenalidomide

Therapeutic Areas

Multiple Myeloma, Lymphoma, Mantle Cell Lymphoma and Myelodysplastic Syndromes

ATC
L04AX06

Name of Medicinal Product

Pomalidomide/Abbio

Active Substance

Pomalidomide

Therapeutic Areas

Multiple Myeloma

ATC
H02AB06

Name of Medicinal Product

Prednisolone/Abbio

Active Substance

Prednisolone

Therapeutic Areas

Immunology, Endocrinology, Anti-inflammatory treatment

Market-Authorized Products Ready For Launch

0

ATC
B01AF01

Name of Medicinal Product

Rivaroxaban/Abbio

Active Substance

Rivaroxaban

Therapeutic Areas

Arthroplasty, Venous Thromboembolism

ATC
B01AF02

Name of Medicinal Product

Apixaban/Abbio

Active Substance

Apixaban

Therapeutic Areas

Arthroplasty, Venous Thromboembolism

ATC
B02BX05

Name of Medicinal Product

Eltrombopag/Abbio

Active Substance

Eltrombopag

Therapeutic Areas

Purpura, Thrombocytopenic, Idiopathic, Anemia, Aplastic

ATC
J01XX09

Name of Medicinal Product

Daptomycin/Abbio

Active Substance

Daptomycin

Therapeutic Areas

Gram-Positive Bacterial Infections, Bacteremia, Soft Tissue Infections, Endocarditis, Bacterial

ATC
J05AF10

Name of Medicinal Product

Entecavir/Abbio

Active Substance

Entecavir

Therapeutic Areas

Hepatitis B, Chronic

ATC
L04AA32

Name of Medicinal Product

Apremilast/Abbio

Active Substance

Apremilast

Therapeutic Areas

Arthritis, Psoriatic, Psoriasis, Behcet Syndrome

ATC
V03AC03

Name of Medicinal Product

Deferasirox/Abbio

Active Substance

Deferasirox

Therapeutic Areas

beta-Thalassemia, Iron Overload

Products Supplied On A Named-Patient Basis

0

ATC
L01AA01

Active Substance

Cyclophosphamide

Therapeutic Areas

Sarcoma, Lymphoma, Lung Cancer, Ovarian cancer, Nephritis

ATC
L01AA06

Active Substance

Ifosfamide

Therapeutic Areas

Testicular Cancer, Soft Tissue Sarcoma, Osteosarcoma

ATC
L01AC01

Active Substance

Thiotepa

Therapeutic Areas

Hematopoietic Stem Cell Transplantation

Bio Products In Launch Preparation

0

ATC
M05BX04

Name of Medicinal Product

Junod

Active Substance

Denosumab

Therapeutic Areas

Bone Resorption, Osteoporosis, Postmenopausal

ATC
M05BX04

Name of Medicinal Product

Yaxwer

Active Substance

Denosumab

Therapeutic Areas

Giant Cell Tumor of Bone, Neoplasms, Bone Tissue

Ongoing Registration Products

0

ATC
C01-001

Therapeutic Areas

Refractory hypotension in adults with septic or other distributive shock

ATC
J01-001

Therapeutic Areas

Second-Generation Cephalosporin

ATC
J02-001

Therapeutic Areas

Candidiasis, Mycoses, Coccidioidomycosis, Aspergillosis

ATC
L01-001

Therapeutic Areas

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ATC
L01-002

Therapeutic Areas

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome

ATC
L01-003

Therapeutic Areas

Myeloproliferative Disorders, Polycythemia Vera, Graft vs Host Disease

ATC
L01-004

Therapeutic Areas

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute

ATC
L01-005

Therapeutic Areas

Hematopoietic Stem Cell Transplantation

ATC
L01-006

Therapeutic Areas

Carcinoma, Renal Cell, Carcinomas, Hepatocellular

ATC
L01-007

Therapeutic Areas

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome

ATC
L01-008

Therapeutic Areas

Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Pulmonary Fibrosis, Scleroderma, Systemic

ATC
L01-009

Therapeutic Areas

Carcinoma, Non-Small-Cell Lung, Mesothelioma

ATC
L01-010

Therapeutic Areas

Carcinoma of the ovary, Breast Cancer, Lung Cancer

ATC
L01-011

Therapeutic Areas

Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Pulmonary Fibrosis, Scleroderma, Systemic

ATC
L01-012

Therapeutic Areas

Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

ATC
L02-001

Therapeutic Areas

Prostatic Neoplasms

ATC
L02-002

Therapeutic Areas

Prostatic Neoplasms

ATC
L04-001

Therapeutic Areas

Multiple Sclerosis

ATC
L04-002

Therapeutic Areas

Multiple Sclerosis

ATC
L04-003

Therapeutic Areas

Multiple Sclerosis

ATC
L04-004

Therapeutic Areas

Multiple Sclerosis

ATC
M05-001

Therapeutic Areas

Hypercalcemia